ArticleCancer research communications2025

An Acrolein-Based Drug Delivery System Enables Tumor-Specific Sphingosine-1-Phosphate Targeting in Breast Cancer without Lymphocytopenia.

Masayuki Nagahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.